The expression of PROS1 mRNA was decreased in the experimental group (peripheral plasma of ICC patients) compared to that in the control group (peripheral plasma of healthy subjects), however, the difference was not statistically significant (P=0.171259). The gene discussed is PROS1; the disease is intrahepatic cholangiocarcinoma.